|
ZBTB46 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.981600E-03 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.476490E-03 |
| Normal-vs-Stage2 |
1.779150E-03 |
| Normal-vs-Stage3 |
4.148400E-01 |
| Normal-vs-Stage4 |
9.907800E-01 |
| Stage1-vs-Stage2 |
1.666590E-01 |
| Stage1-vs-Stage3 |
3.439800E-02 |
| Stage1-vs-Stage4 |
1.627740E-02 |
| Stage2-vs-Stage3 |
1.079650E-02 |
| Stage2-vs-Stage4 |
3.217900E-03 |
| Stage3-vs-Stage4 |
4.966400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.310000E-02 |
| Normal-vs-AfricanAmerican |
7.872000E-02 |
| Normal-vs-Asian |
1.039580E-02 |
| Caucasian-vs-AfricanAmerican |
5.096800E-01 |
| Caucasian-vs-Asian |
2.481400E-01 |
| AfricanAmerican-vs-Asian |
8.569600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.450500E-02 |
| Normal-vs-Female |
7.921500E-03 |
| Male-vs-Female |
9.879000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.824790E-03 |
| Normal-vs-Age(41-60Yrs) |
6.637100E-03 |
| Normal-vs-Age(61-80Yrs) |
3.266200E-01 |
| Normal-vs-Age(81-100Yrs) |
5.302400E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.507000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.309800E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
9.511700E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
9.580400E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.882970E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.689000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.220560E-04 |
| Classical-VS-Follicular |
1.298010E-01 |
| Classical-VS-Other |
3.902600E-01 |
| Classical-VS-Normal |
4.367700E-04 |
| Tall-VS-Follicular |
2.149500E-02 |
| Tall-VS-Other |
3.775800E-01 |
| Tall-VS-Normal |
3.033000E-01 |
| Follicular-VS-Other |
7.277600E-01 |
| Follicular-VS-Normal |
1.250570E-01 |
| Other-VS-Normal |
7.323400E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
7.360400E-03 |
| Normal-vs-N1 |
6.481600E-01 |
| N0-vs-N1 |
1.165170E-01 |
|
|
